Antimicrobial Resistance in ESKAPE PathogensDavid M. P. De Oliveira, Mark J. Walker, Brian M. Forde et al.|Clinical Microbiology Reviews|2020Cited by 2k
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone ResistancePatrick N. A. Harris, David L. Paterson, Paul Anantharajah Tambyah et al.|JAMA|2018Cited by 761
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Elena Salamanca et al.|The Lancet Infectious Diseases|2017Cited by 521
The emerging threat of multidrug-resistant Gram-negative bacteria in urologyHosam M. Zowawi, David L. Paterson, Patrick N. A. Harris et al.|Nature Reviews Urology|2015Cited by 367
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, H. R. Cross, Greg Weston et al.|The Lancet Infectious Diseases|2021Cited by 338